These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3542803)

  • 21. Single-blind study of dystrophin staining in carriers of Duchenne muscular dystrophy.
    Bernier FP; Greenberg CR; Halliday WC; Wrogemann K
    Can J Neurol Sci; 1993 Feb; 20(1):44-7. PubMed ID: 8467428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.
    Monckton G; Zatz M; Mion CS; Marusyk H
    Am J Hum Genet; 1984 Jul; 36(4):926-30. PubMed ID: 6475962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomographic findings in manifesting carriers of Duchenne muscular dystrophy.
    de Visser M; Verbeeten B
    Clin Genet; 1985 Mar; 27(3):269-75. PubMed ID: 3987077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method for the detection of carriers of Duchenne muscular dystrophy--a preliminary report.
    Monckton G; Marusyk H; Pehowich E
    Am J Hum Genet; 1981 Nov; 33(6):978-86. PubMed ID: 7325161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 30. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis.
    Emery AE
    Br Med Bull; 1980 May; 36(2):117-22. PubMed ID: 7020836
    [No Abstract]   [Full Text] [Related]  

  • 31. [Duchenne muscular dystrophy: detection of carriers using ultrasound].
    Rott HD; Mulz D
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1678-81. PubMed ID: 7140545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
    Norman A; Harper P
    Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal precision in ultrasound attenuation estimation and application to the detection of Duchenne muscular dystrophy carriers.
    Berger G; Laugier P; Fink M; Perrin J
    Ultrason Imaging; 1987 Jan; 9(1):1-17. PubMed ID: 3299966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of carrier status in Duchenne dystrophy by creatine kinase measurement.
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Blasco PA; Hassler CR; Nance WE
    Am J Clin Pathol; 1985 Nov; 84(5):655-8. PubMed ID: 4061390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.